Publication

Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococal vaccine: a randomized, controlled evaluation

Authored by:

Shahid NS, Steinhoff MC, Roy E et al.

Full Citation:

Shahid NS, Steinhoff MC, Roy E et al. 2002. Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococal vaccine: a randomized, controlled evaluation. Vaccine. 20(17-18).

View Publication

Additional key concepts from this publication:

The benefits of maternal immunization are magnified through breastfeeding.

Key Evidence: The breastmilk of mothers in Bangladesh who received the meningococcal vaccine during pregnancy had anti-meningococcal antibody levels at 3-6 months after delivery of four to five times higher than that of mothers who did not receive the vaccine.

From the VoICE Editors: Although this study was published in 2002, the data on this topic are sparse as it is methodologically difficult to conduct studies to evaluate the relationship between anti-meningococcal antibodies in breastmilk and protection.